{
    "applicationNumber": "BR 11 2013 030352-2",
    "filingDate": "01/06/2012",
    "grantDate": "19/05/2020",
    "title": "ANTICORPO  ANTI-FCRN  ISOLADO,  COMPOSI\u00c7\u00c3O  FARMAC\u00caUTICA QUE COMPREENDE O DITO ANTICORPO, \u00c1CIDO NUCLEICO ISOLADO, VETOR, C\u00c9LULA E USO TERAP\u00caUTICO DO DITO ANTICORPO",
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "61/492,617",
            "priorityDate": "02/06/2011"
        },
        {
            "countryCode": "US",
            "priorityNumber": "61/498,266",
            "priorityDate": "17/06/2011"
        }
    ],
    "events": [
        {
            "code": "7.5",
            "description": "Notifica\u00e7\u00e3o de Anu\u00eancia relacionada com o Art. 229-C da LPI",
            "bulletinNumber ": "2532"
        },
        {
            "code": "6.21",
            "description": "Exig\u00eancia preliminar - pedidos com buscas realizadas por outros Escrit\u00f3rios de Patentes",
            "bulletinNumber ": "2542"
        },
        {
            "code": "9.1",
            "description": "Deferimento",
            "bulletinNumber ": "2567"
        },
        {
            "code": "16.1",
            "description": "Concess\u00e3o de Patente ou Certificado de Adi\u00e7\u00e3o de Inven\u00e7\u00e3o",
            "bulletinNumber ": "2576"
        },
        {
            "code": "25.1",
            "description": "Transfer\u00eancia Deferida",
            "bulletinNumber ": "2636"
        }
    ],
    "inventors": [
        "DANIEL J SEXTON",
        "CHRISTOPHER TENHOOR",
        "MALINI VISWANATHAN"
    ],
    "holders": [
        118618
    ],
    "ipcCodes": [
        "A61K 39/395",
        "C07H 21/04",
        "C07K 16/00"
    ]
}